Rosalind Sharain, M.D., and Nooshin Karamzadeh Dashti, M.D., have been named Chief Fellows for the Surgical Pathology Fellowship Program for the academic year 2017–18.
Mayo Clinic Laboratory and pathology research roundup: February 7 - Insights
This week's Research Roundup features: Maintenance of remission and risk of relapse in Myeloperoxidase-positive ANCA-associated Vasculitis with kidney involvement.
Mayo Clinic Laboratory and pathology research roundup: March 21 - Insights
This week's Research Roundup features: Performance comparisons of methylation and structural variants from low-input whole-genome methylation sequencing.
Mayo Clinic Laboratory and pathology research roundup: April 4 - Insights
This week's Research Roundup features: Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021.
Mayo Clinic Laboratory and pathology research roundup: April 18 - Insights
This week's Research Roundup feature: Renal involvement in systemic sclerosis.
Mayo Clinic Laboratory and pathology research roundup: April 25 - Insights
This week's Research Roundup feature: Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.
Mayo Clinic Laboratory and pathology research roundup: March 14 - Insights
This week's Research Roundup features: Novel through-the-scope suture closure of colonic Endoscopic Mucosal resection defects.
Mayo Clinic Laboratory and pathology research roundup: March 28 - Insights
This week's Research Roundup features: Elementary overview of heavy metals.
Mayo Clinic Laboratory and pathology research roundup: March 8 - Insights
This week’s research roundup features: Androgen deprivation therapy use and duration with definitive radiotherapy for localized prostate cancer: an individual patient data meta-analysis.
From Michigan to Mayo for Esoteric Lab Needs - Insights
Munson Healthcare, an eight-hospital system, has worked with Mayo Clinic Laboratories for more than 30 years. The system’s community hospital labs provide basic testing, but Munson turns to Mayo Clinic Laboratories for its highly...
Clinical Pathology
Anatomic Pathology
Week in Review: May 20 - Insights
Today's highlights include: US at risk of COVID-19 drug shortages this summer, Rochester startup Vyriad developing cancer-fighting viruses, and CDC expresses concern about possibility of undetected monkeypox spread in U.K.
Week in Review: May 13 - Insights
Today's highlights include: Pandemic gets tougher to track as COVID testing plunges, Rochester hospitals score top grades in safety, and Mayo Clinic breaks ground on $155M Minnesota hospital expansion.
COVID-19 weekly news: April 4-10 2022 - Insights
Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.
Mayo Clinic Laboratory and pathology research roundup: December 28 - Insights
This week’s research roundup features: Risk of late-onset breast cancer in genetically predisposed women.
Mayo Clinic Laboratory and pathology research roundup: November 30 - Insights
This week’s research roundup features: Tumor junction burden and antigen presentation as predictors of survival in mesothelioma treated with immune checkpoint inhibitors.
Mayo Clinic Laboratory and pathology research roundup: January 18 - Insights
Today's Topic Features: Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt...
Clinical Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
Bonner General Health in Sandpoint, Idaho, has selected Mayo Medical Laboratories as its primary reference laboratory. This selection gives Bonner General Health access to Mayo Clinic’s extensive menu of laboratory tests and clinical...
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Helicobacter pylori - Insights
Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.
Pathology consultation - Insights
Learn more about how Mayo Clinic Laboratories consultative pathology practice, which is supported by more than 100 board-certified pathologists, can provide expertise on any case.
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
In vitro diagnostics solutions - Insights
BioPharma Diagnostics supports medical device, biopharma, and diagnostic companies with in vitro diagnostic services, including analytical validation of new assays and devices in compliance with CAP/CLIA requirements.
Pharmaceutical solutions - Insights
We believe the pharmaceutical industry and clinical research partners can improve global health through innovative drug discovery and development — and that you deserve the best reference lab partner at your side. Mayo Clinic BioPharma...
Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.
Mayo Clinic Laboratories’ genetic counselors are experts on heritable illness who provide a wealth of knowledge to guide appropriate testing utilization and interpret results.
Learn more about how our flexible lab space and expert staff can help you meet your diagnostic needs.
Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.
Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.
Precision mental and behavioral health therapeutics - Insights
Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.
Emergency toxicology - Insights
Mayo Clinic Laboratories’ emergency toxicology testing can help providers manage overdose by clarifying whether symptoms are due to the presence of drugs.
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Myelodysplastic syndrome - Insights
Browse our wide variety of testing options for the prognosis and risk stratification associated with myelodysplastic syndrome.
See how our Special Coagulation Laboratory offers algorithmic approaches to meet your bleeding disorder testing needs.
Disease-specific panels - Insights
Learn how disease-specific cancer panels help providers understand their patients’ risk of having a hereditary cancer syndrome.
Comprehensive panels - Insights
Learn how our in-depth genetic testing can determine whether a cancer is hereditary in origin for individuals with a family history of cancer.
Hereditary Colon Cancer Testing - Mayo Clinic Laboratories
Our algorithmic approach aids with the ordering process and guides physicians to ensure the right tests are being ordered at the right time for patients.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.
Autoimmune Dementia Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune dementia contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Children's Oncology Group - Insights
Learn how our team’s commitment and large testing menu helps in meeting the specific needs of Children’s Oncology Group patients.
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
Learn how our muscular dystrophy genetic testing can help patients access variant-specific therapies and determine eligibility for clinical trials.
Hereditary hearing loss - Insights
Learn how our hereditary hearing loss test can help avoid unnecessary workups and appointments and reduce anxiety for patients and their families.
Amyloidosis Testing - Mayo Clinic Laboratories
Mayo Clinic’s amyloid protein identification methodology is considered the gold standard because of the high sensitivity and accuracy with which it types amyloid proteins in paraffin-embedded specimens.
Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights
This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.